Q3 2022 13F Holders as of 30 Sep 2022
-
Type / Class
-
Equity / Voting Common Shares, no par value
-
Shares outstanding
-
51,654,406
-
Total 13F shares
-
2,527,104
-
Share change
-
-1,141,318
-
Total reported value
-
$3,132,035
-
Price per share
-
$1.24
-
Number of holders
-
23
-
Value change
-
-$2,355,232
-
Number of buys
-
10
-
Number of sells
-
10
Institutional Holders of DiaMedica Therapeutics Inc. - Voting Common Shares, no par value (DMAC) as of Q3 2022
As of 30 Sep 2022 DiaMedica Therapeutics Inc. - Voting Common Shares, no par value (DMAC) had 23 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 2,527,104 shares of stock of the company.
Largest 10 holders included COOPERMAN LEON G, VANGUARD GROUP INC, JACOB ASSET MANAGEMENT OF NEW YORK LLC, GEODE CAPITAL MANAGEMENT, LLC, NORTHERN TRUST CORP, BlackRock Inc., STATE STREET CORP, MORGAN STANLEY, DIMENSIONAL FUND ADVISORS LP, and Bank of New York Mellon Corp.
This table shows 23 institutional shareholders of the security as of 30 Sep 2022.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.